Tumor-associated macrophages (TAMs) are a type of immune cell found within the tumor microenvironment that often promote tumor growth and metastasis by supporting angiogenesis, suppressing anti-tumor immune responses, and remodeling the extracellular matrix. Targeting TAMs is a promising therapeutic strategy in cancer treatment, aiming to reprogram or deplete these cells to enhance anti-tumor immunity.